FI964095A0 - Intranasal antimigren komposition - Google Patents

Intranasal antimigren komposition

Info

Publication number
FI964095A0
FI964095A0 FI964095A FI964095A FI964095A0 FI 964095 A0 FI964095 A0 FI 964095A0 FI 964095 A FI964095 A FI 964095A FI 964095 A FI964095 A FI 964095A FI 964095 A0 FI964095 A0 FI 964095A0
Authority
FI
Finland
Prior art keywords
composition
migraine
intranasal
intranasal anti
spray device
Prior art date
Application number
FI964095A
Other languages
English (en)
Finnish (fi)
Other versions
FI964095A (sv
FI118295B (sv
Inventor
Marc Karel Jozef Francois
Roger Carolus August Embrechts
Lisbeth Illum
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI964095A publication Critical patent/FI964095A/sv
Publication of FI964095A0 publication Critical patent/FI964095A0/sv
Application granted granted Critical
Publication of FI118295B publication Critical patent/FI118295B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI964095A 1994-04-13 1996-10-11 Intranasal antimigren komposition FI118295B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP94200998 1994-04-13
EP94200998 1994-04-13
EP9501302 1995-04-10
PCT/EP1995/001302 WO1995028158A1 (en) 1994-04-13 1995-04-10 Intranasal antimigraine composition

Publications (3)

Publication Number Publication Date
FI964095A FI964095A (sv) 1996-10-11
FI964095A0 true FI964095A0 (sv) 1996-10-11
FI118295B FI118295B (sv) 2007-09-28

Family

ID=8216793

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964095A FI118295B (sv) 1994-04-13 1996-10-11 Intranasal antimigren komposition

Country Status (23)

Country Link
EP (1) EP0755253B1 (sv)
JP (1) JP2921988B2 (sv)
KR (1) KR100219952B1 (sv)
CN (1) CN1146151A (sv)
AT (1) ATE194915T1 (sv)
AU (1) AU684360B2 (sv)
BG (1) BG62197B1 (sv)
BR (1) BR9507369A (sv)
CA (1) CA2184822C (sv)
CZ (1) CZ286610B6 (sv)
DE (1) DE69518149T2 (sv)
FI (1) FI118295B (sv)
HR (1) HRP950149A2 (sv)
HU (1) HU219495B (sv)
IL (1) IL113341A (sv)
NO (1) NO310276B1 (sv)
NZ (1) NZ284454A (sv)
PL (1) PL179761B1 (sv)
RO (1) RO115414B1 (sv)
SI (1) SI9500121A (sv)
SK (1) SK129896A3 (sv)
WO (1) WO1995028158A1 (sv)
ZA (1) ZA953038B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403905D0 (sv) * 1994-11-14 1994-11-14 Astra Ab New formulations
KR970032844A (ko) * 1995-12-29 1997-07-22 김준웅 지속성 경비투여제제
UA72189C2 (uk) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
GB2378383A (en) * 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
GB0328186D0 (en) 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
US7968122B2 (en) 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
GB8904370D0 (en) * 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
JPH0656675A (ja) * 1992-08-07 1994-03-01 Nippon Soda Co Ltd 家畜の乳房炎予防剤

Also Published As

Publication number Publication date
ATE194915T1 (de) 2000-08-15
CZ292096A3 (en) 1997-02-12
HU9602806D0 (en) 1996-11-28
AU2305495A (en) 1995-11-10
KR100219952B1 (ko) 1999-09-01
JP2921988B2 (ja) 1999-07-19
CN1146151A (zh) 1997-03-26
HU219495B (hu) 2001-04-28
IL113341A0 (en) 1995-07-31
RO115414B1 (ro) 2000-02-28
FI964095A (sv) 1996-10-11
BG62197B1 (bg) 1999-05-31
FI118295B (sv) 2007-09-28
HRP950149A2 (en) 1997-06-30
HUT75939A (en) 1997-05-28
NZ284454A (en) 1997-12-19
EP0755253B1 (en) 2000-07-26
BR9507369A (pt) 1997-09-23
DE69518149D1 (de) 2000-08-31
CZ286610B6 (cs) 2000-05-17
AU684360B2 (en) 1997-12-11
SK129896A3 (en) 1997-05-07
CA2184822A1 (en) 1995-10-26
ZA953038B (en) 1996-10-14
IL113341A (en) 2000-08-31
EP0755253A1 (en) 1997-01-29
NO310276B1 (no) 2001-06-18
CA2184822C (en) 2000-12-19
BG100889A (en) 1997-07-31
SI9500121A (en) 1995-10-31
PL316756A1 (en) 1997-02-03
NO964333D0 (no) 1996-10-11
PL179761B1 (pl) 2000-10-31
DE69518149T2 (de) 2001-03-22
NO964333L (no) 1996-10-11
WO1995028158A1 (en) 1995-10-26
JPH09505606A (ja) 1997-06-03

Similar Documents

Publication Publication Date Title
MY113733A (en) Salts of an anti-migraine indole derivative
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
UA66750C2 (en) Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors
ZA988158B (en) Sulfinic acid derivatives and their preparation and use
FI964095A (sv) Intranasal antimigren komposition
NO180334C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive difluorstatonanaloger
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
ATE493112T1 (de) Nasensalbe auf basis von vaselin
MX9604690A (es) Composicion antimigraña intranasal.
MX9603348A (es) Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa.
MXPA03006057A (es) Proceso para preparar (+) trans-4-p-fluorofenil -3 hidroximetil.
BR9914532A (pt) Processo de preparação de uma solução para pulverização nasal que contém um ou vários hormÈnios sexuais e uma ciclodextrina
PL353291A1 (en) Novel compounds, method of obtaining them, their application as pigments and composition containing them
ES2170377T3 (es) Composicion que contiene quitosana.
FI925618A0 (fi) Etanoladdukter av 6-sulfonylsubstituerade 3-hydroxikromaner och deras anvaendning som inhalationsmedel vid sjukdomar
ES8601690A1 (es) Un procedimiento para la obtencion de preparados del bifanazol con elevada liberacion del producto actuvo
IL122537A0 (en) Arylalkoxyphenoxy-imidazoline compounds process for their preparation and pharmaceutical compositions containing them
MY114151A (en) Analogs of thymosin
ES8606375A1 (es) Un procedimiento para preparar un derivado de aminoprpilaminobleomicina
EP0687670A4 (en) OPTICALLY ACTIVE FLUBROCYTHRINATE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF
KR940004779U (ko) 안개식 분무기등의 카브레타에어발생방지 체크밸브겸용노즐
BR0107129A (pt) Composição de substância carreadora de produtos

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 118295

Country of ref document: FI

MA Patent expired